Diabetes-related adduct formation and retinopathy

Alan W Stitt1, Timothy M Curtis

  • 1Centre for Vision and Vascular Science, Queen's University Belfast, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA Northern Ireland UK.

Insights

Diabetic retinopathy is driven by advanced glycation and lipoxidation end products (AGEs/ALEs) damaging retinal cells. Inhibiting AGE/ALE formation or receptor interactions may prevent vision loss in diabetes.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Biochemistry

Background:

  • Diabetic retinopathy pathogenesis involves complex metabolic abnormalities, with hyperglycemia and dyslipidemia damaging the retina.
  • The retina is highly sensitive to metabolic damage, necessitating research into its biochemical and molecular basis.
  • Advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs) are implicated in diabetic retinopathy progression.

Purpose of the Study:

  • To review the formation and impact of AGEs and ALEs on retinal cells in diabetic retinopathy.
  • To explore the role of the receptor for AGEs (RAGE) in modulating retinal pathology, including oxidative stress and inflammation.
  • To discuss strategies for inhibiting AGE/ALE formation and receptor interactions to prevent diabetic retinopathy progression.

Main Methods:

  • Review of existing literature on AGE/ALE formation and their role in diabetic retinopathy.
  • Analysis of mechanisms underlying retinal cell dysfunction and death due to AGEs/ALEs.
  • Discussion of the impact of RAGE signaling on retinal pathology.

Main Results:

  • AGEs and ALEs are key contributors to diabetic retinopathy, causing retinal cell dysfunction and death.
  • RAGE signaling exacerbates retinal pathology through oxidative stress and inflammation.
  • Understanding these pathways provides targets for therapeutic intervention.

Conclusions:

  • AGE/ALE formation and RAGE interactions are critical in diabetic retinopathy.
  • Inhibiting these pathways offers potential strategies to prevent sight-threatening complications.
  • Early intervention from diabetes diagnosis is crucial for managing disease progression.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...